Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

Abroad (travel likely)RecruitingPHASE2

Conditions

Allergic Asthma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ruijin Hospital, Shanghai, China
Contact: Study coordinator (Wei Tang) · tina_tangwei@163.com · +86 189170 0579

Study leads

Jieming Qu
Principal Investigator
Ruijin Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma

Allergic Asthma

Abroad (travel likely)RecruitingPHASE2

Kaohsiung City, Taiwan · Kaohsiung City, Taiwan

ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar

Chronic Spontaneous Urticaria (CSU) · Allergic Asthma

Abroad (travel likely)Recruiting

Montpellier, France

Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma

Allergic Rhinitis · Allergic Asthma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Zurich, Switzerland

Viral Mucosal Reprogramming

Asthma · Allergic Rhinitis · Cat Allergy

Abroad (travel likely)RecruitingPHASE2

Galveston, United States